Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Stock Analysis Checklist
Atea Pharmaceuticals, Inc. AVIR
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 3.36
-2.89 %
$ 288 M
Market Cap
-2.04
P/E
Price Target
Average
104.76%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
45.77%
Net Income
Estimate
23.93%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Atea Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for
AVIR
of
$6.88
, with forecasts ranging from a low of
$6.88
to a high of
$6.88
.
AVIR Lowest Price Target
Wall Street Target
6.88 USD
104.76%
AVIR Average Price Target
Wall Street Target
6.88 USD
104.76%
AVIR Highest Price Target
Wall Street Target
6.88 USD
104.76%
Price
Max Price Target
Min Price Target
Average Price Target
7
7
7
7
6
6
6
6
5
5
5
5
4
4
4
4
3
3
3
3
Sep '24
Sep '24
Nov '24
Nov '24
2025
2025
Feb '25
Feb '25
Apr '25
Apr '25
Jun '25
Jun '25
Jul '25
Jul '25
Aug '25
Aug '25
Oct '25
Oct '25
Nov '25
Nov '25
2026
2026
Feb '26
Feb '26
Apr '26
Apr '26
Jun '26
Jun '26
Jul '26
Jul '26
REVENUE FORECAST
Revenue Forecast Chart
AVIR
$400.0m
$400.0m
$350.0m
$350.0m
$300.0m
$300.0m
$250.0m
$250.0m
$200.0m
$200.0m
$150.0m
$150.0m
$100.0m
$100.0m
$50.0m
$50.0m
$0.0
$0.0
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
EBIT FORECAST
EBIT Forecast Chart
AVIR
$200.0m
$200.0m
$150.0m
$150.0m
$100.0m
$100.0m
$50.0m
$50.0m
$0.0
$0.0
($50.0m)
($50.0m)
($100.0m)
($100.0m)
($150.0m)
($150.0m)
($200.0m)
($200.0m)
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
NET INCOME FORECAST
Net Income Chart
AVIR
$800.0m
$800.0m
$700.0m
$700.0m
$600.0m
$600.0m
$500.0m
$500.0m
$400.0m
$400.0m
$300.0m
$300.0m
$200.0m
$200.0m
$100.0m
$100.0m
$0.0
$0.0
($100.0m)
($100.0m)
($200.0m)
($200.0m)
2020
2020
2021
2021
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Free
forever, no credit card required
$
0
/ Mon
Up to 3 Valuations Access per week
Only 1 Watchlist
Select
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Add Note
Capture your thoughts
Note
Sell
Buy
Hold
Pass